Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2025 Feb 28

PMID 40016948

Authors

Simone E M Olsthoorn

Anneloes van Krimpen

Rudi W Hendriks

Ralph Stadhouders

Affiliations

Soon will be listed here.

Abstract

Asthma is a common chronic inflammatory disease of the airways. A substantial number of patients present with severe and therapy-resistant asthma, for which the underlying biological mechanisms remain poorly understood. In most asthma patients, airway inflammation is characterized by chronic activation of type 2 immunity. CD4 T helper 2 (Th2) cells are the canonical producers of the cytokines that fuel type 2 inflammation: interleukin (IL)-4, IL-5, IL-9, and IL-13. However, more recent findings have shown that other lymphocyte subsets, in particular group 2 innate lymphoid cells (ILC2s) and type 2 CD8 cytotoxic T (Tc2) cells, can also produce large amounts of type 2 cytokines. Importantly, a substantial number of severe therapy-resistant asthma patients present with chronic type 2 inflammation, despite the high sensitivity of Th2 cells for suppression by corticosteroids-the mainstay drugs for asthma. Emerging evidence indicates that ILC2s and Tc2 cells are more abundant in severe asthma patients and can adopt corticosteroid-resistance states. Moreover, many severe asthma patients do not present with overt type 2 airway inflammation, implicating non-type 2 immunity as a driver of disease. In this review, we will discuss asthma pathophysiology and focus on the roles played by ILC2s, Tc2 cells, and non-type 2 lymphocytes, placing special emphasis on severe disease forms.

References

Kiniwa T, Moro K . Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells. Int Immunol. 2021; 33(5):251-259. PMC: 8060991. DOI: 10.1093/intimm/dxab001. View

Message S, Laza-Stanca V, Mallia P, Parker H, Zhu J, Kebadze T . Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008; 105(36):13562-7. PMC: 2528869. DOI: 10.1073/pnas.0804181105. View

Marone G, Granata F, Pucino V, Pecoraro A, Heffler E, Loffredo S . The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma. Front Pharmacol. 2019; 10:1387. PMC: 6908970. DOI: 10.3389/fphar.2019.01387. View

Shih H, Sciume G, Mikami Y, Guo L, Sun H, Brooks S . Developmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality. Cell. 2016; 165(5):1120-1133. PMC: 4874839. DOI: 10.1016/j.cell.2016.04.029. View

Qi C, Xu C, Koppelman G . The role of epigenetics in the development of childhood asthma. Expert Rev Clin Immunol. 2019; 15(12):1287-1302. DOI: 10.1080/1744666X.2020.1686977. View

Papadopoulos N, Stanciu L, Papi A, Holgate S, Johnston S . A defective type 1 response to rhinovirus in atopic asthma. Thorax. 2002; 57(4):328-32. PMC: 1746310. DOI: 10.1136/thorax.57.4.328. View

Huang Y, Guo L, Qiu J, Chen X, Hu-Li J, Siebenlist U . IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. Nat Immunol. 2014; 16(2):161-9. PMC: 4297567. DOI: 10.1038/ni.3078. View

Hurrell B, Sakano Y, Shen S, Helou D, Li M, Shafiei-Jahani P . Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector function. Sci Transl Med. 2024; 16(746):eadk4728. DOI: 10.1126/scitranslmed.adk4728. View

OSullivan S, Cormican L, Faul J, Ichinohe S, Johnston S, Burke C . Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med. 2001; 164(4):560-4. DOI: 10.1164/ajrccm.164.4.2102018. View

10.

van der Ploeg E, Krabbendam L, Vroman H, van Nimwegen M, de Bruijn M, de Boer G . Type-2 CD8 T-cell formation relies on interleukin-33 and is linked to asthma exacerbations. Nat Commun. 2023; 14(1):5137. PMC: 10447424. DOI: 10.1038/s41467-023-40820-x. View

11.

Calderon A, Dimond C, Choy D, Pappu R, Grimbaldeston M, Mohan D . Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. Eur Respir Rev. 2023; 32(167). PMC: 9879340. DOI: 10.1183/16000617.0144-2022. View

12.

Gelfand E, Hinks T . Is there a role for type 2 CD8 T cells in patients with steroid-resistant asthma?. J Allergy Clin Immunol. 2019; 144(3):648-650. DOI: 10.1016/j.jaci.2019.07.022. View

13.

Pelaia C, Paoletti G, Puggioni F, Racca F, Pelaia G, Canonica G . Interleukin-5 in the Pathophysiology of Severe Asthma. Front Physiol. 2020; 10:1514. PMC: 6927944. DOI: 10.3389/fphys.2019.01514. View

14.

Ohne Y, Silver J, Thompson-Snipes L, Collet M, Blanck J, Cantarel B . IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat Immunol. 2016; 17(6):646-55. DOI: 10.1038/ni.3447. View

15.

Flamar A, Klose C, Moeller J, Mahlakoiv T, Bessman N, Zhang W . Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity. Immunity. 2020; 52(4):606-619.e6. PMC: 7218677. DOI: 10.1016/j.immuni.2020.02.009. View

16.

Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord I . Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019; 199(12):1471-1477. DOI: 10.1164/rccm.201810-1868CI. View

17.

Molofsky A, Van Gool F, Liang H, Van Dyken S, Nussbaum J, Lee J . Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity. 2015; 43(1):161-74. PMC: 4512852. DOI: 10.1016/j.immuni.2015.05.019. View

18.

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

19.

Allinne J, Scott G, Lim W, Birchard D, Erjefalt J, Sanden C . IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation. J Allergy Clin Immunol. 2019; 144(6):1624-1637.e10. DOI: 10.1016/j.jaci.2019.08.039. View

20.

Guo L, Wei G, Zhu J, Liao W, Leonard W, Zhao K . IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A. 2009; 106(32):13463-8. PMC: 2726336. DOI: 10.1073/pnas.0906988106. View